Journal of Cardiac Failure
Volume 13, Issue 4 , Pages 275-280 , May 2007

Amino Terminal B-Type Natriuretic Peptide, Renal Function, and Prognosis in Acute Heart Failure: A Hospital Cohort Study

  • Joana Martins Pimenta, MD

      Affiliations

    • From the Departments of Internal Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
    • Corresponding Author InformationReprint requests: Joana Martins Pimenta, MD, Hospital de S. João, Faculdade de Medicina da Universidade do Porto, Porto 4200–319, Portugal.
    • ,
  • Rui Almeida, MD

      Affiliations

    • Cardiology, Hospital de S. João, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
    • ,
  • José Paulo Araújo, MD

      Affiliations

    • From the Departments of Internal Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
    • ,
  • Ana Azevedo, MD

      Affiliations

    • From the Departments of Internal Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
    • ,
  • Fernando Friões, MD

      Affiliations

    • From the Departments of Internal Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
    • ,
  • Francisco Rocha-Gonçalves, MD, PhD

      Affiliations

    • Cardiology, Hospital de S. João, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
    • ,
  • António Ferreira, MD, PhD

      Affiliations

    • From the Departments of Internal Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
    • ,
  • Paulo Bettencourt, MD, PhD

      Affiliations

    • From the Departments of Internal Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal

Received 27 June 2006 ,Revised 28 December 2006 ,Accepted 4 January 2007.

References 

  1. Berry C, Hogg K, Norrie J, Stevenson K, Brett M, McMurray J. Heart failure with preserved left ventricular systolic function: a hospital cohort study. Heart. 2005;91:907–913
  2. McCullough PA, Duc P, Omland T, McCord J, Nowak RM, Hollander JE, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis. 2003;41:571–579
  3. Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement. Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol. 2006;47:91–97
  4. Meyer KB, Levey AS. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task force on Cardiovascular Disease. J Am Soc Nephrol. 1998;9:S31–S42
  5. Coresh J, Astor B, Sarnak M. Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2004;13:73–81
  6. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307–1315
  7. McCullough PA. Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med. 2002;3:71–76
  8. Zoccali C. Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention. Nephrol Dial Transplant. 2002;17(Suppl 11):50–54
  9. Schrier RW. Role of diminished renal function in cardiovascular mortality. Marker or pathogenetic factor?. J Am Coll Cardiol. 2006;47:1–8
  10. Ishizaka Y, Yamamoto Y, Tanaka M, Kato F, Ishizaka Y, Yokota N, et al. Molecular forms of human brain natriuretic peptide (BNP) in plasma of patients on hemodialysis (HD). Clin Nephrol. 1995;43:237–242
  11. Haug C, Metzele A, Steffgen J, Kochs M, Hombach V, Grunert A. Increased brain natriuretic peptide and atrial peptide plasma concentration in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Clin Invest. 1994;72:430–434
  12. Franz M, Woloszczuk W, Hörl WH. Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases. Kidney Int. 2001;59:1928–1934
  13. McCullough PA, Sandberg KR. B-type natriuretic peptide and renal disease. Heart Fail Rev. 2003;8:355–358
  14. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115–1140
  15. Bayes-Genis A, Lopez L, Zapico E, Cotes C, Santalo M, Ordonez-Llanos J, et al. NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality. J Card Fail. 2005;11:S3–S8
  16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;330:877–884
  17. Bettencourt PM. Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives. Heart. 2005;91:1489–1494
  18. Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J. 2003;24:1710–1718
  19. Silver MA, Maisel A, Yancy CW, McCullough PA, Burnett JC, Francis GS, et al. BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail. 2004;10:1–30
  20. Doust JA, Pietrzak E, Dobson A, Glasziou PP. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ. 2005;330:625
  21. McCullough PA, Sandberg KR. Sorting out the evidence on natriuretic peptides. Rev Cardiovasc Med. 2003;4(Suppl 4):S13–S19
  22. van Kimmenade RRJ, Januzzi JL, Baggish AL, Lainchbury JG, Bayes-Genis A, Richards M, et al. Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure. Redefining the cardiorenal interaction?. J Am Coll Cardiol. 2006;48:1621–1627
  23. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. N-terminal pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation. 2004;110:22168–22174
  24. O'Brien RJ, Squire IB, Demme B, Davies JE, Ng LL. Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF. Eur J Heart Fail. 2003;5:499–506
  25. Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation. 2004;110:1780–1786

PII: S1071-9164(07)00002-4

doi: 10.1016/j.cardfail.2007.01.001

Journal of Cardiac Failure
Volume 13, Issue 4 , Pages 275-280 , May 2007

Article Tools

* Image Usage & Resolution